Nkarta NKTX
NASDAQ NKTX
$2.66 +0.19 (+7.69%)
At close: Aug 21, 2026 · 4:00 PM EDT

Nkarta (NKTX) Change in Acquisitions & Divestments (2020 - 2026)

Nkarta (NKTX) posted quarterly Change in Acquisitions & Divestments of $70.6 million for Q1 2026, down 6.4% year-over-year from $75.4 million in Q1 2025, and down 24.15% quarter-over-quarter from $93.1 million in Q4 2025.

Nkarta (NKTX) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends

Nkarta's Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $70.6 million for Q1 2026.

  • In Q1 2026, Change in Acquisitions & Divestments fell 6.4% year-over-year to $70.6 million; the TTM figure through Mar 2026 stood at $335.3 million (up 13.66% YoY), while the FY2025 annual figure was $340.1 million, up 20.93% from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 stood at $70.6 million, down from $93.1 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $126.0 million in Q1 2023, with the low at $29.2 million in Q1 2022.
  • The 5-year median for Change in Acquisitions & Divestments is $75.4 million (2025), against an average of $76.9 million.
  • The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments plunged 53.69% in 2022, then surged 331.41% in 2023.
  • Nkarta's Change in Acquisitions & Divestments stood at $115.4 million in 2022, then decreased by 25.45% to $86.0 million in 2023, then fell by 4.3% to $82.3 million in 2024, then advanced by 13.1% to $93.1 million in 2025, then decreased by 24.15% to $70.6 million in 2026.
  • Business Quant data shows NKTX's Change in Acquisitions & Divestments at $70.6 million in Q1 2026, $93.1 million in Q4 2025, and $83.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Nkarta 201.14 Mn 201.14 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 63.70 Mn
Jun 30, 2026 63.70 Mn
Mar 31, 2026 70.61 Mn
Mar 31, 2026 70.61 Mn
Dec 31, 2025 93.08 Mn
Dec 31, 2025 93.08 Mn
Sep 30, 2025 83.16 Mn
Sep 30, 2025 83.16 Mn
Jun 30, 2025 88.42 Mn
Jun 30, 2025 88.42 Mn
Mar 31, 2025 75.44 Mn
Mar 31, 2025 75.44 Mn
Dec 31, 2024 82.30 Mn
Dec 31, 2024 82.30 Mn
Sep 30, 2024 68.23 Mn
Sep 30, 2024 68.23 Mn
Jun 30, 2024 69.00 Mn
Jun 30, 2024 69.00 Mn
Mar 31, 2024 61.70 Mn
Mar 31, 2024 61.70 Mn